首页|神经内镜辅助去骨瓣血肿清除术治疗高血压脑出血患者的效果

神经内镜辅助去骨瓣血肿清除术治疗高血压脑出血患者的效果

扫码查看
目的:观察神经内镜辅助去骨瓣血肿清除术治疗高血压脑出血患者的效果.方法:选取 2020 年 6 月至 2022 年 6 月该院收治的 100 例高血压脑出血患者进行前瞻性研究,按随机数字表法将其分为对照组与研究组各 50 例.对照组采用小骨窗开颅术治疗,研究组采用神经内镜辅助去骨瓣血肿清除术治疗.比较两组手术相关指标水平、手术前后神经损伤指标[神经元特异性烯醇化酶(NSE)、胶质纤维酸性蛋白(GFAP)、中枢神经特异性蛋白(S100β)]水平、神经功能缺损程度[美国国立卫生研究院卒中量表(NIHSS)]评分、临床疗效和并发症发生率.结果:研究组手术时间、住院时间均短于对照组,术中出血量少于对照组,血肿清除率高于对照组,差异有统计学意义(P<0.05);术后 1 周,两组NSE、GFAP、S100β水平均低于术前,且研究组均低于对照组,差异有统计学意义(P<0.05);术后1个月,两组NIHSS评分均低于术前,且研究组低于对照组,差异有统计学意义(P<0.05);研究组治疗总有效率为78.00%(39/50),高于对照组的 54.00%(27/50),差异有统计学意义(P<0.05);两组并发症发生率比较,差异无统计学意义(P>0.05).结论:神经内镜辅助去骨瓣血肿清除术治疗高血压脑出血患者可提高治疗总有效率,改善手术相关指标水平,降低神经损伤指标水平与神经缺损程度评分,其效果优于小骨窗开颅术治疗.
Effects of neuroendoscopy-assisted bone flap hematoma removal in treatment of patients with hypertensive cerebral hemorrhage
Objective:To observe effects of neuroendoscopy-assisted bone flap hematoma removal in treatment of patients with hypertensive cerebral hemorrhage.Methods:A prospective study was conducted on 100 patients with hypertensive cerebral hemorrhage admitted to the hospital from June 2020 to June 2022.According to the random number table method,they were divided into control group and study group,50 cases in each group.The control group was treated with small bone window craniotomy,while the study group was treated with neuroendoscopy-assisted bone flap hematoma removal.The levels of operation-related indexes,and nerve injury indexes[neuron-specific enolase(NSE),glial fibrillary acidic protein(GFAP),central nervous system specific protein(S100β)]before and after the surgery,the neurological deficit degree[National Institutes of Health stroke scale(NIHSS)]score,the clinical efficacy,and the incidence of complications were compared between the two groups.Results:The operation time and the hospitalization time of the study group were shorter than those of the control group,the intraoperative blood loss was less than that of the control group,the hematoma clearance rate was higher than that of the control group,and the differences were statistically significant(P<0.05).1 week after the surgery,the levels of NSE,GFAP and S100β in the two groups were lower than those before the surgery,those in the study group were lower than those in t the control group,and the differences were statistically significant(P<0.05).1 month after the surgery,the NIHSS scores of the two groups were lower than those before the surgery,that in the study group was lower than that in the control group,and the differences were statistically significant(P<0.05).The total effective rate of treatment in the study group was 78.00% (39/50),which was higher than 54.00% (27/50)in the control group,and the difference was statistically significant(P<0.05).However,there was no significant difference in the incidence of complications between the two groups(P>0.05).Conclusions:Neuroendoscopy-assisted bone flap hematoma removal in the treatment of the patients with hypertensive cerebral hemorrhage can improve the total effective rate of treatment,improve the levels of operation-related indicators,and reduce the levels of nerve injury indexes and the scores of neurological deficit degree.Moreover,it is superior to small bone window craniotomy.

Hypertensive cerebral hemorrhageNeuroendoscopyBone flap hematoma removalSmall bone window craniotomyNerve injuryComplication

张华园、梁春东、张海军

展开 >

开封市中心医院神经外科,河南 开封 475000

高血压脑出血 神经内镜 去骨瓣血肿清除术 小骨窗开颅术 神经损伤 并发症

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(4)
  • 15